Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women:: a double-blind, randomized, controlled study

被引:172
作者
Marteau, P
Cuillerier, E
Meance, S
Gerhardt, MF
Myara, A
Bouvier, M
Bouley, C
Tondu, F
Bommelaer, G
Grimaud, JC
机构
[1] Hop Europeen Georges Pompidou, Dept Gastroenterol, Serv Hepatogastroenterol, F-75908 Paris 15, France
[2] Danone Vitapole, Nutr Res Grp, Le Plessis Robinson, France
[3] St Joseph Hosp, Dept Biochem, Paris, France
[4] Hop Nord Marseille, Dept Gastroenterol, Marseille, France
[5] Ctr Hosp & Univ, Dept Gastroenterol, Clermont Ferrand, France
关键词
D O I
10.1046/j.1365-2036.2002.01188.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: A previous study has suggested that Bifidobacterium animalis DN-173 010 shortens the colonic transit time in women. Aim: To confirm this effect and to determine whether modifications of the faecal bacterial mass and/or faecal secondary bile salts may be the explanation. Methods: A double-blind, cross-over study was performed. Thirty-six healthy women were studied in four consecutive 10-day periods. During periods 2 and 4, they ingested three 125 g cups per day of a fermented milk which was either a product containing B. animalis DN-173 010 or a control without bifidobacteria. Periods 1 and 3 were run-in and washout periods, respectively. The total and segmental colonic transit times were assessed using a pellet method. In 12 subjects, all stools were collected and analysed for pH, faecal weight. bacterial mass and bile acids. Results: The total and sigmoid transit times were significantly shorter during dosing with B. animalis compared to the control period. The other transit times, faecal weight, pH. bacterial mass and bile acids were not significantly affected. Conclusions: B. animalis DN-173 010 shortens the colonic transit time in healthy women. This effect is not explained by modifications or the faecal bacterial mass or secondary bile acids.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 27 条
[1]  
Ballonge J, 1998, LACTIC ACID BACTERIA, P519
[2]   BIFIDOBACTERIUM FROM FERMENTED MILKS - SURVIVAL DURING GASTRIC TRANSIT [J].
BERRADA, N ;
LEMELAND, JF ;
LAROCHE, G ;
THOUVENOT, P ;
PIAIA, M .
JOURNAL OF DAIRY SCIENCE, 1991, 74 (02) :409-413
[3]  
Biasco G, 1991, Eur J Cancer Prev, V1 Suppl 2, P63, DOI 10.1097/00008469-199110002-00011
[4]  
Bouglé D, 1999, SCAND J GASTROENTERO, V34, P144, DOI 10.1080/00365529950172998
[5]   FECAL RECOVERY IN HUMANS OF VIABLE BIFIDOBACTERIUM SP INGESTED IN FERMENTED MILK [J].
BOUHNIK, Y ;
POCHART, P ;
MARTEAU, P ;
ARLET, G ;
GODEREL, I ;
RAMBAUD, JC .
GASTROENTEROLOGY, 1992, 102 (03) :875-878
[6]  
BOUVIER M, IN PRESS BIOSCI MICR
[7]  
CARGILL G, 1992, PRESSE MED, V21, P19
[8]   DETERMINATION OF TOTAL AND SEGMENTAL COLONIC TRANSIT-TIME IN CONSTIPATED PATIENTS - RESULTS IN 91 PATIENTS WITH A NEW SIMPLIFIED METHOD [J].
CHAUSSADE, S ;
KHYARI, A ;
ROCHE, H ;
GARRET, M ;
GAUDRIC, M ;
COUTURIER, D ;
GUERRE, J .
DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (08) :1168-1172
[9]   A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces [J].
Duez, H ;
Pelletier, C ;
Cools, S ;
Aissi, E ;
Cayuela, C ;
Gavini, F ;
Bouquelet, S ;
Neut, C ;
Mengaud, J .
JOURNAL OF APPLIED MICROBIOLOGY, 2000, 88 (06) :1019-1027
[10]   THE EFFECT OF MILK AND LACTOBACILLUS FEEDING ON HUMAN INTESTINAL BACTERIAL ENZYME-ACTIVITY [J].
GOLDIN, BR ;
GORBACH, SL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1984, 39 (05) :756-761